Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1979 Nov;16(5):625–630. doi: 10.1128/aac.16.5.625

Agar disk diffusion susceptibility characteristics of azlocillin, carbenicillin, mezlocillin, piperacillin, and ticarcillin.

D Phaneuf, H C Neu
PMCID: PMC352917  PMID: 118706

Abstract

The agar disk diffusion susceptibility of Enterobacteriaceae to mezlocillin and piperacillin was correlated with agar minimal inhibitory concentrations and compared with the susceptibility to carbenicillin. The agar disk susceptibility of Pseudomonas aeruginosa to azlocillin, mezlocillin, and piperacillin was correlated with agar minimal inhibitory concentrations and compared with the susceptibility to carbenicillin and ticarcillin. Criteria are offered for the zones of inhibition to provide information about resistant and susceptible isolates that correlate with known serum levels.

Full text

PDF
625

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Fiegel P., Becker K. Pharmacokinetics of azlocillin in persons with normal and impaired renal functions. Antimicrob Agents Chemother. 1978 Sep;14(3):288–291. doi: 10.1128/aac.14.3.288. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Fu K. P., Neu H. C. Azlocillin and mezlocillin: new ureido penicillins. Antimicrob Agents Chemother. 1978 Jun;13(6):930–938. doi: 10.1128/aac.13.6.930. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Fu K. P., Neu H. C. Piperacillin, a new penicillin active against many bacteria resistant to other penicillins. Antimicrob Agents Chemother. 1978 Mar;13(3):358–367. doi: 10.1128/aac.13.3.358. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Issell B. F., Bodey G. P., Weaver S. Clinical pharmacology of mezlocillin. Antimicrob Agents Chemother. 1978 Feb;13(2):180–183. doi: 10.1128/aac.13.2.180. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Jones R. N., Thornsberry C., Barry A. L., Fuchs P. C., Gavan T. L., Gerlach E. H. Piperacillin (T-1220), a new semisynthetic penicillin: in vitro antimicrobial activity comparison with carbenicillin, ticarcillin, ampicillin, cephalothin, cefamandole and cefoxitin. J Antibiot (Tokyo) 1977 Dec;30(12):1107–1114. doi: 10.7164/antibiotics.30.1107. [DOI] [PubMed] [Google Scholar]
  6. Neu H. C., Garvey G. J. Comparative in vitro activity and clinical pharmacology of ticarcillin and carbenicillin. Antimicrob Agents Chemother. 1975 Oct;8(4):457–462. doi: 10.1128/aac.8.4.457. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Pancoast S. J., Neu H. C. Kinetics of mezlocillin and carbenicillin. Clin Pharmacol Ther. 1978 Jul;24(1):108–116. doi: 10.1002/cpt1978241108. [DOI] [PubMed] [Google Scholar]
  8. Parry M. F., Neu H. C. Comparison and evaluation of ticarcillin and carbenicillin using disk diffusion methods. Antimicrob Agents Chemother. 1976 Apr;9(4):625–632. doi: 10.1128/aac.9.4.625. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Prior R. B., Fass R. J. Proposed ticarcillin disk control values for Escherichia coli and Pseudomonas aeruginosa: multicenter cooperative study. Antimicrob Agents Chemother. 1978 Sep;14(3):507–508. doi: 10.1128/aac.14.3.507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Verbist L. In vitro activity of piperacillin, a new semisynthetic penicillin with an unusually broad spectrum of activity. Antimicrob Agents Chemother. 1978 Mar;13(3):349–357. doi: 10.1128/aac.13.3.349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Winston D. J., Wang D., Young L. S., Martin W. J., Hewitt W. L. In vitro studies of piperacilin, a new semisynthetic penicillin. Antimicrob Agents Chemother. 1978 Jun;13(6):944–950. doi: 10.1128/aac.13.6.944. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES